Europe Immunodiagnostics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Immunodiagnostics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Immunodiagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Immunodiagnostics Market Regional Analysis

6.2 Europe Immunodiagnostics Market Revenue 2021-2030 (US$ Million)

6.3 Europe Immunodiagnostics Market Forecast Analysis

7. Europe Immunodiagnostics Market Analysis – by Product

7.1 Enzyme-Linked Immunosorbent Assays

7.1.1 Overview
7.1.2 Enzyme-Linked Immunosorbent Assays: Europe Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)

7.2 Chemiluminescence Immunoassays

7.2.1 Overview
7.2.2 Chemiluminescence Immunoassays: Europe Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)

7.3 Radioimmunoassays

7.3.1 Overview
7.3.2 Radioimmunoassays: Europe Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)

8. Europe Immunodiagnostics Market Analysis – by Clinical Indication

8.1 Infectious Diseases

8.1.1 Overview
8.1.2 Infectious Diseases: Europe Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)

8.2 Hepatitis+HIV

8.2.1 Overview
8.2.2 Hepatitis+HIV: Europe Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)

8.3 Endocrinology

8.3.1 Overview
8.3.2 Endocrinology: Europe Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)

8.4 Gastrointestinal

8.4.1 Overview
8.4.2 Gastrointestinal: Europe Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)

8.5 Metabolics

8.5.1 Overview
8.5.2 Metabolics: Europe Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)

9. Europe Immunodiagnostics Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Hospitals: Europe Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)

9.2 Clinics

9.2.1 Overview
9.2.2 Clinics: Europe Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)

9.3 Diagnostic Laboratories

9.3.1 Overview
9.3.2 Diagnostic Laboratories: Europe Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)

9.4 Academic & Research Institutes

9.4.1 Overview
9.4.2 Academic & Research Institutes: Europe Immunodiagnostics Market – Revenue and Forecast, 2021-2030 (US$ Million)

10. Europe Immunodiagnostics Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe Immunodiagnostics Market Breakdown, by Key Country, 2024 and 2030 (%)
10.2.1.1 Europe Immunodiagnostics Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: Europe Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.1.1 UK: Europe Immunodiagnostics Market Breakdown, by Product
10.2.1.1.2 UK: Europe Immunodiagnostics Market Breakdown, by Clinical Indication
10.2.1.1.3 UK: Europe Immunodiagnostics Market Breakdown, by End User

10.2.1.2 Germany: Europe Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.2.1 Germany: Europe Immunodiagnostics Market Breakdown, by Product
10.2.1.2.2 Germany: Europe Immunodiagnostics Market Breakdown, by Clinical Indication
10.2.1.2.3 Germany: Europe Immunodiagnostics Market Breakdown, by End User

10.2.1.3 France: Europe Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.3.1 France: Europe Immunodiagnostics Market Breakdown, by Product
10.2.1.3.2 France: Europe Immunodiagnostics Market Breakdown, by Clinical Indication
10.2.1.3.3 France: Europe Immunodiagnostics Market Breakdown, by End User

10.2.1.4 Russia: Europe Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.4.1 Russia: Europe Immunodiagnostics Market Breakdown, by Product
10.2.1.4.2 Russia: Europe Immunodiagnostics Market Breakdown, by Clinical Indication
10.2.1.4.3 Russia: Europe Immunodiagnostics Market Breakdown, by End User

10.2.1.5 Italy: Europe Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.5.1 Italy: Europe Immunodiagnostics Market Breakdown, by Product
10.2.1.5.2 Italy: Europe Immunodiagnostics Market Breakdown, by Clinical Indication
10.2.1.5.3 Italy: Europe Immunodiagnostics Market Breakdown, by End User

10.2.1.6 Rest of Europe: Europe Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe Immunodiagnostics Market Breakdown, by Product
10.2.1.6.2 Rest of Europe: Europe Immunodiagnostics Market Breakdown, by Clinical Indication
10.2.1.6.3 Rest of Europe: Europe Immunodiagnostics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 bioMerieux SA

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Danaher Corp

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 DiaSorin SpA

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 F. Hoffmann-La Roche Ltd

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 PerkinElmer Inc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Siemens Healthcare GmbH

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Svar Life Science AB

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Thermo Fisher Scientific Inc

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe Immunodiagnostics Market